Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this study, we examined the effects of alteplase, a recombinant tissue-type plasminogen activator (t-PA), in a simple and reproducible rat middle cerebral artery (MCA) occlusion model induced by photoillumination with 12 mg/kg of rose bengal. A clinically equivalent dose of alteplase (3 mg/kg), which was administered just after thrombotic occlusion of the MCA, significantly reopened the thrombotic MCA occlusion in 16 of 23 animals (69.6%) when compared with vehicle-treated animals (8 of 22 animals, 36.4%). In addition, alteplase significantly reduced cerebral damage and improved neurological deficits. Although it has been reported that t-PA possesses neurotoxicity, the present findings suggest that alteplase was effective in a rat acute stroke model due to reopening of thrombotic MCA occlusion. This new model is very useful for investigating the efficacy of thrombolytic agents in stroke research, providing a condition similar to the clinical setting. Copyright © 2009 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Umemura, K., Higo, K., Sakata, T., Yuki, S., Iwata, K., & Yamaguchi, K. (2008). Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model. Pathophysiology of Haemostasis and Thrombosis, 36(5), 245–250. https://doi.org/10.1159/000252820

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free